McKesson and CD&R to Take Option Care Health Private in $5.8 Billion Deal
McKesson and private equity firm Clayton Dubilier & Rice (CD&R) have agreed to acquire Option Care Health, the largest independent US provider of medical infusion services, for $5.8 billion including debt. The deal values the company at $32.05 per share, representing a 37% premium to its recent closing price. CD&R will hold a 51% stake, while McKesson will hold the minority interest with the right to buy out CD&R in the future. The acquisition reflects a broader trend of healthcare services companies being bought at lower valuation multiples, driven by rising demand for complex biologic medicines administered via infusion.
